Q77.1

Clinical Causes: Genetic mutations affecting the development of cartilage and bones Inheriting mutations in the FGFR3 gene, which plays a significant role in bone growth and development De novo mutations that are not inherited from parents

Key Symptoms: Extreme short stature apparent at birth, often with a body length less than 30 centimeters (approximately 12 inches) Bulging forehead (bossing) C-shaped or cloverleaf-shaped skull (craniosynostosis) Severe underdevelopment of the ribs and chest cavity Abnormal bone curvature and limb shortening Facial features that include a prominent forehead and flattened nasal bridge Limited lung development due to small chest size, leading to breathing difficulties

Diagnosis Path: Diagnosis typically involves a combination of prenatal ultrasound imaging and postnatal physical examination. Key diagnostic steps include: - Prenatal ultrasound revealing abnormal bone measurements and skull shape - Radiographic imaging to identify characteristic skeletal abnormalities - Genetic testing to analyze mutations in the FGFR3 gene, - Differential diagnosis to differentiate from similar skeletal dysplasias Postnatal assessment confirms the severity of bone deformities and assesses respiratory function, which is often compromised.

Treatment Protocols: Management of thanatophoric short stature is primarily supportive and symptomatic. Approaches may include: - Ensuring adequate respiratory support, which may involve mechanical ventilation for newborns with breathing difficulties - Nutritional support to promote growth where possible - Surgical interventions to correct deformities or improve function of the limbs and spine - Multidisciplinary care involving pediatric genetics, orthopedics, pulmonology, and other specialists Given the prognosis, many affected infants face significant health challenges, and treatments focus on comfort and supportive care. Palliative care options are also considered essential in managing quality of life.